Andrew Emerson
Executive Vice President And Chief Financial Officer
Idexx Laboratories Inc · IDXX
$3M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A filed March 27, 2026. Prior years are from that filing's three-year table.
Catalog as of September 15, 2026. Not a live market feed.
- Salary
- $531K
- Stock Awards
- $950K
- Option Awards
- $950K
- Incentives
- $578K
- Other
- $25K
Compensation History
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $531,146 | $949,864 | $3,033,071 |
Current Position
- Company
- Idexx Laboratories Inc
- Title
- Executive Vice President And Chief Financial Officer
- Ticker
- IDXX · NASDAQ
- Fiscal Year
- 2025
SEC Sources
Fiscal years below are columns from the latest DEF 14A Summary Compensation Table (filed March 27, 2026), not separate historical filings.
| Fiscal Year | Source |
|---|---|
| 2025 | View SEC filing |
Accession 0000874716-26-000064.
Other Idexx Laboratories Executives
Jonathan J. Mazelsky
President And Chief Executive Officer
Idexx Laboratories · IDXX
$14.6M
FY 2025 · DEF 14A
Michael J. Lane
Executive Vice President And General Manager, Cag Diagnostics Business Unit
Idexx Laboratories · IDXX
$4M
FY 2025 · DEF 14A
Tina Hunt Ph DExecutive
Vice President, Global Strategy And Commercial
Idexx Laboratories · IDXX
$3.9M
FY 2025 · DEF 14A
Martin Smith Ph
D Executive Vice President And Chief Technology Officer, R&d, Global Operations, Information Technology And Information Security
Idexx Laboratories · IDXX
$3.9M
FY 2025 · DEF 14A
Brian P. McKeon
Former Executive Vice President, Chief Financial Officer And Treasurer
Idexx Laboratories · IDXX
$352K
FY 2025 · DEF 14A